
GRAIL, Inc. (GRAL)
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
- Previous Close
108.98 - Open
108.51 - Bid 100.37 x 600
- Ask 101.46 x 200
- Day's Range
99.47 - 108.90 - 52 Week Range
20.44 - 118.84 - Volume
1,036,291 - Avg. Volume
979,570 - Market Cap (intraday)
3.937B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-10.66 - Earnings Date Nov 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
115.00
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
grail.com1,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: GRAL
View MorePerformance Overview: GRAL
Trailing total returns as of 1/28/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends: GRAL
View MoreAnalyst Insights: GRAL
View MoreStatistics: GRAL
View MoreValuation Measures
Market Cap
4.25B
Enterprise Value
3.77B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
26.87
Price/Book (mrq)
1.90
Enterprise Value/Revenue
26.56
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-286.43%
Return on Assets (ttm)
-11.06%
Return on Equity (ttm)
-16.83%
Revenue (ttm)
141.83M
Net Income Avi to Common (ttm)
-406.24M
Diluted EPS (ttm)
-10.66
Balance Sheet and Cash Flow
Total Cash (mrq)
540.13M
Total Debt/Equity (mrq)
2.62%
Levered Free Cash Flow (ttm)
-59.18M
Compare To: GRAL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights: GRAL
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: GRAL
View MoreDaily – Vickers Top Buyers & Sellers for 12/08/2025
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 11/20/2025
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 10/17/2025
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 10/09/2025
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.




